Cargando…
Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction
OBJECTIVE: Cartilage health is maintained in response to a range of mechanical stimuli including compressive, shear and tensile strains and associated alterations in osmolality. The osmotic-sensitive ion channel Transient Receptor Potential Vanilloid 4 (TRPV4) is required for mechanotransduction. Me...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders For The Osteoarthritis Research Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799379/ https://www.ncbi.nlm.nih.gov/pubmed/33395574 http://dx.doi.org/10.1016/j.joca.2020.08.002 |
_version_ | 1783635121570578432 |
---|---|
author | Fu, S. Meng, H. Inamdar, S. Das, B. Gupta, H. Wang, W. Thompson, C.L. Knight, M.M. |
author_facet | Fu, S. Meng, H. Inamdar, S. Das, B. Gupta, H. Wang, W. Thompson, C.L. Knight, M.M. |
author_sort | Fu, S. |
collection | PubMed |
description | OBJECTIVE: Cartilage health is maintained in response to a range of mechanical stimuli including compressive, shear and tensile strains and associated alterations in osmolality. The osmotic-sensitive ion channel Transient Receptor Potential Vanilloid 4 (TRPV4) is required for mechanotransduction. Mechanical stimuli inhibit interleukin-1β (IL-1β) mediated inflammatory signalling, however the mechanism is unclear. This study aims to clarify the role of TRPV4 in this response. DESIGN: TRPV4 activity was modulated glycogen synthase kinase (GSK205 antagonist or GSK1016790 A (GSK101) agonist) in articular chondrocytes and cartilage explants in the presence or absence of IL-1β, mechanical (10% cyclic tensile strain (CTS), 0.33 Hz, 24hrs) or osmotic loading (200mOsm, 24hrs). Nitric oxide (NO), prostaglandin E(2) (PGE(2)) and sulphated glycosaminoglycan (sGAG) release and cartilage biomechanics were analysed. Alterations in post-translational tubulin modifications and primary cilia length regulation were examined. RESULTS: In isolated chondrocytes, mechanical loading inhibited IL-1β mediated NO and PGE(2) release. This response was inhibited by GSK205. Similarly, osmotic loading was anti-inflammatory in cells and explants, this response was abrogated by TRPV4 inhibition. In explants, GSK101 inhibited IL-1β mediated NO release and prevented cartilage degradation and loss of mechanical properties. Upon activation, TRPV4 cilia localisation was increased resulting in histone deacetylase 6 (HDAC6)-dependent modulation of soluble tubulin and altered cilia length regulation. CONCLUSION: Mechanical, osmotic or pharmaceutical activation of TRPV4 regulates HDAC6-dependent modulation of ciliary tubulin and is anti-inflammatory. This study reveals for the first time, the potential of TRPV4 manipulation as a novel therapeutic mechanism to supress pro-inflammatory signalling and cartilage degradation. |
format | Online Article Text |
id | pubmed-7799379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | W.B. Saunders For The Osteoarthritis Research Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-77993792021-01-19 Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction Fu, S. Meng, H. Inamdar, S. Das, B. Gupta, H. Wang, W. Thompson, C.L. Knight, M.M. Osteoarthritis Cartilage Article OBJECTIVE: Cartilage health is maintained in response to a range of mechanical stimuli including compressive, shear and tensile strains and associated alterations in osmolality. The osmotic-sensitive ion channel Transient Receptor Potential Vanilloid 4 (TRPV4) is required for mechanotransduction. Mechanical stimuli inhibit interleukin-1β (IL-1β) mediated inflammatory signalling, however the mechanism is unclear. This study aims to clarify the role of TRPV4 in this response. DESIGN: TRPV4 activity was modulated glycogen synthase kinase (GSK205 antagonist or GSK1016790 A (GSK101) agonist) in articular chondrocytes and cartilage explants in the presence or absence of IL-1β, mechanical (10% cyclic tensile strain (CTS), 0.33 Hz, 24hrs) or osmotic loading (200mOsm, 24hrs). Nitric oxide (NO), prostaglandin E(2) (PGE(2)) and sulphated glycosaminoglycan (sGAG) release and cartilage biomechanics were analysed. Alterations in post-translational tubulin modifications and primary cilia length regulation were examined. RESULTS: In isolated chondrocytes, mechanical loading inhibited IL-1β mediated NO and PGE(2) release. This response was inhibited by GSK205. Similarly, osmotic loading was anti-inflammatory in cells and explants, this response was abrogated by TRPV4 inhibition. In explants, GSK101 inhibited IL-1β mediated NO release and prevented cartilage degradation and loss of mechanical properties. Upon activation, TRPV4 cilia localisation was increased resulting in histone deacetylase 6 (HDAC6)-dependent modulation of soluble tubulin and altered cilia length regulation. CONCLUSION: Mechanical, osmotic or pharmaceutical activation of TRPV4 regulates HDAC6-dependent modulation of ciliary tubulin and is anti-inflammatory. This study reveals for the first time, the potential of TRPV4 manipulation as a novel therapeutic mechanism to supress pro-inflammatory signalling and cartilage degradation. W.B. Saunders For The Osteoarthritis Research Society 2021-01 /pmc/articles/PMC7799379/ /pubmed/33395574 http://dx.doi.org/10.1016/j.joca.2020.08.002 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fu, S. Meng, H. Inamdar, S. Das, B. Gupta, H. Wang, W. Thompson, C.L. Knight, M.M. Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction |
title | Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction |
title_full | Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction |
title_fullStr | Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction |
title_full_unstemmed | Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction |
title_short | Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction |
title_sort | activation of trpv4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking il-1β mediated articular cartilage matrix destruction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799379/ https://www.ncbi.nlm.nih.gov/pubmed/33395574 http://dx.doi.org/10.1016/j.joca.2020.08.002 |
work_keys_str_mv | AT fus activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction AT mengh activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction AT inamdars activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction AT dasb activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction AT guptah activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction AT wangw activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction AT thompsoncl activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction AT knightmm activationoftrpv4bymechanicalosmoticorpharmaceuticalstimulationisantiinflammatoryblockingil1bmediatedarticularcartilagematrixdestruction |